All Insights
Showing 109 - 120 of 415
Dispute resolution
UK courts' new EU case law departure powers due to enter into force later in 2024
New powers to depart from assimilated EU and domestic case law contained in the Retained EU Law Act are set
Digital commerce, platforms and social media
The Country of Origin Principle: How Far Does Protection Extend for Online Service Providers?
The CJEU reiterates its stance on the invalidity of additional requirements imposed on an online provider by a Member State
UK General Election
UK general election: what are the potential implications for the life sciences and healthcare sector?
The Conservative and Labour parties both acknowledge the sector's importance to the UK's economic growth, but what plans do they
Competition, antitrust and trade
Government updates guidance on the UK National Security and Investment Act
Changes cover call-in powers, universities and research bodies, outward direct investment and notification forms
Urban Dynamics
Future Foods Update | May 2024
This edition includes new UK guidance on plant-based dairy products, an Austrian case on naming plant-based products, and EU developments
Intellectual property
The UK is developing its approach to deregulating gene editing in plants
The UK has pursued a post-Brexit deregulatory agenda via new legislation but has it failed to capitalise on the changes?
Artificial intelligence
What should employers in Belgium consider when using AI in the workplace?
Artificial intelligence has enormous potential from recruitment to termination, but the regulatory landscape is evolving fast
Intellectual property
Orders to preserve evidence under the Unified Patent Court: seven trends from the emerging case law
The UPC has demonstrated a flexible approach – and so far has routinely granted ex parte orders to preserve evidence
Intellectual property
What qualifies as a legitimate reason to object to parallel trade of medicines in Europe?
Trade mark owners are able to object to the parallel trade of medicines provided that there are legitimate reasons
Intellectual property
What are the patentability implications of deregulating gene editing in plants in the EU?
The European Parliament has voted to embrace more flexibility in the regulation of gene-edited plants but has proposed a ban
Intellectual property
UK Supreme Court finds sales of trade marked goods from US website targeted UK consumers for infringement purposes
US website's targeting of UK consumers amounted to infringing trade mark use in the UK and EU, but no decision
Intellectual property
Updated EPO examination guidelines address AI, accelerated oppositions and antibody claims
The European Patent Office's new guidelines entered into force on 1 March
